Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

HDM1005

Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes

Huadong Medicine · Phase 3 · Recruiting · Enrollment 825

NCT07279194

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
HDM1005 Cohort 1n/rn/rn/rn/r
HDM1005 Cohort 2n/rn/rn/rn/r
Placebon/rn/rn/rn/r

Not shown

  • HDM1005 Cohort 1: endpoint not reported
  • HDM1005 Cohort 2: endpoint not reported
  • Placebo: endpoint not reported